JPS59161379A - γ−ブチロラクトン誘導体、その製造方法及びそれを含有する薬剤 - Google Patents

γ−ブチロラクトン誘導体、その製造方法及びそれを含有する薬剤

Info

Publication number
JPS59161379A
JPS59161379A JP58209771A JP20977183A JPS59161379A JP S59161379 A JPS59161379 A JP S59161379A JP 58209771 A JP58209771 A JP 58209771A JP 20977183 A JP20977183 A JP 20977183A JP S59161379 A JPS59161379 A JP S59161379A
Authority
JP
Japan
Prior art keywords
group
compound
mixture
solvent
ether
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP58209771A
Other languages
English (en)
Japanese (ja)
Inventor
クロ−ド・ベルナ−ル
ベルナ−・カウトレ−ルズ
パトリツク・ゴテイエ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi SA
Original Assignee
Sanofi SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi SA filed Critical Sanofi SA
Publication of JPS59161379A publication Critical patent/JPS59161379A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/57—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
JP58209771A 1982-11-08 1983-11-08 γ−ブチロラクトン誘導体、その製造方法及びそれを含有する薬剤 Pending JPS59161379A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8218705 1982-11-08
FR8218705A FR2535722B1 (fr) 1982-11-08 1982-11-08 Derives de la g-butyrolactone protecteurs du myocarde presentant une activite antiarythmique, procede pour leur preparation et medicaments en contenant

Publications (1)

Publication Number Publication Date
JPS59161379A true JPS59161379A (ja) 1984-09-12

Family

ID=9278999

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58209771A Pending JPS59161379A (ja) 1982-11-08 1983-11-08 γ−ブチロラクトン誘導体、その製造方法及びそれを含有する薬剤

Country Status (29)

Country Link
US (1) US4542134A (enExample)
EP (1) EP0113600B1 (enExample)
JP (1) JPS59161379A (enExample)
KR (1) KR900006723B1 (enExample)
AT (1) ATE28644T1 (enExample)
AU (1) AU560032B2 (enExample)
CA (1) CA1224467A (enExample)
CS (1) CS244680B2 (enExample)
DD (2) DD231567A5 (enExample)
DE (1) DE3372767D1 (enExample)
DK (1) DK503683A (enExample)
ES (1) ES527092A0 (enExample)
FI (1) FI79538C (enExample)
FR (1) FR2535722B1 (enExample)
GR (1) GR78746B (enExample)
HU (1) HU192825B (enExample)
IE (1) IE56208B1 (enExample)
IL (1) IL70062A (enExample)
MA (1) MA19947A1 (enExample)
NO (1) NO159853C (enExample)
NZ (1) NZ206176A (enExample)
OA (1) OA07581A (enExample)
PH (1) PH19547A (enExample)
PL (2) PL142949B1 (enExample)
PT (1) PT77606B (enExample)
SG (1) SG2389G (enExample)
SU (1) SU1279529A1 (enExample)
YU (2) YU220483A (enExample)
ZA (1) ZA837935B (enExample)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3714173A (en) * 1971-07-06 1973-01-30 Smith Kline French Lab Pyridyl ketipate lactones and derivatives
FR2467200A1 (fr) * 1979-10-11 1981-04-17 Clin Midy Derives du pyrrole actifs sur les troubles du rythme cardiovasculaire

Also Published As

Publication number Publication date
ES8406071A1 (es) 1984-07-01
NO159853B (no) 1988-11-07
PL139945B1 (en) 1987-03-31
CS244680B2 (en) 1986-08-14
KR840006646A (ko) 1984-12-01
IL70062A (en) 1987-02-27
EP0113600B1 (fr) 1987-07-29
GR78746B (enExample) 1984-10-02
NO159853C (no) 1989-02-15
PL249775A1 (en) 1985-05-07
MA19947A1 (fr) 1984-07-01
AU2063983A (en) 1984-05-17
FI79538C (fi) 1990-01-10
EP0113600A1 (fr) 1984-07-18
OA07581A (fr) 1985-03-31
FR2535722A1 (fr) 1984-05-11
IL70062A0 (en) 1984-01-31
NZ206176A (en) 1985-12-13
DK503683D0 (da) 1983-11-03
CA1224467A (en) 1987-07-21
YU220483A (en) 1986-04-30
IE832580L (en) 1984-05-08
KR900006723B1 (ko) 1990-09-20
SU1279529A3 (ru) 1986-12-23
SG2389G (en) 1991-01-04
DD220313A5 (de) 1985-03-27
YU143585A (en) 1986-04-30
FI79538B (fi) 1989-09-29
IE56208B1 (en) 1991-05-22
PL244461A1 (en) 1985-01-30
PH19547A (en) 1986-05-20
FR2535722B1 (fr) 1985-06-28
AU560032B2 (en) 1987-03-26
FI834069L (fi) 1984-05-09
PL142949B1 (en) 1987-12-31
US4542134A (en) 1985-09-17
DK503683A (da) 1984-05-09
NO834053L (no) 1984-05-09
ES527092A0 (es) 1984-07-01
PT77606A (fr) 1983-12-01
ATE28644T1 (de) 1987-08-15
SU1279529A1 (ru) 1986-12-23
ZA837935B (en) 1984-06-27
FI834069A0 (fi) 1983-11-07
PT77606B (fr) 1986-03-18
DD231567A5 (de) 1986-01-02
HU192825B (en) 1987-07-28
DE3372767D1 (en) 1987-09-03
CS821983A2 (en) 1985-10-16

Similar Documents

Publication Publication Date Title
Mailhol et al. Enantioselective organocatalytic Michael addition of cyclobutanones to nitroalkenes
US2985657A (en) 1-(aroylalkyl)-4-heterocyclylpiperazines
EP0934311A2 (de) Neue heterocyclylmethyl-substituierte pyrazolderivate und ihre verwendung in der behandlung von herz-kreislauf-erkrankungen
US4155909A (en) 2-Alkyl nicotinoids and processes for their production
CA1221967A (en) Derivatives of piperidinedione for protecting the myocardium presenting an anti-arrythmic activity, process for preparing them and drugs containing said derivatives
US3412154A (en) Amino-substituted phenone compounds
JPS59161379A (ja) γ−ブチロラクトン誘導体、その製造方法及びそれを含有する薬剤
JPH01106880A (ja) 新規なアミノアルキル置換複素環硫黄化合物
CA1124738A (en) 3,4-methano pyrrolidine derivatives, compositions thereof and use as plant-growth regulating agents
JPS6135194B2 (enExample)
Zhang et al. Controllable synthesis of pyrazolo [3, 4-b] pyridines or substituted malononitrile derivatives through multi-component reactions in ionic liquid
Borne et al. Synthesis and cholinergic activity of some structural analogs of pilocarpine
JP4457211B2 (ja) ナフトキノン誘導体化合物又はその薬理学的に許容される塩、並びに、それらを有効成分として含有するＣｄｃ２５ホスファターゼ阻害剤及び抗腫瘍剤
Kuzmić et al. Synthesis of new furan polycycles via photochemical reaction in neutral and acidic medium
US4980478A (en) Process for producing substituted vinyl pyridine derivatives
JP2003321405A (ja) ジヒドロピラン化合物およびアルコール化合物の製造方法
Percival Approaches to a total synthesis of pilocarpine
Cazin et al. Improvement in the enantioselectivity of the hydrogen transfer with NADH models bearing amino alcohols as chiral auxiliaries
JPS63170335A (ja) ｄｌ−ｃｉｓ−菊酸の先駆物質の合成法
Percival Alternative formats
Bartman et al. Transmission of substituent effects. Correlation of methyl to hydrogen rate ratios in diverse heterocyclic systems with CNDO/2 parameters
AT371448B (de) Verfahren zur herstellung von neuen cis-4a-phenyl -isochinolin-derivaten und ihren saeureadditionssalzen
Arustamyan et al. Synthesis and Antiarrhythmic Activity of New Benzodioxol-substituted 4-Spiro [cycloalkane (tetrahydropyran)-6, 7-dimethoxy-1, 2, 3, 4-tetrahydroisoquinolines]
Lu et al. Synthesis of 2, 2-difunctionalized 2 H-azirines via I 2-mediated annulation of enamines
Colin et al. New access to fluorinated ketoglycolic acid derivatives from trifluoropyruvamides